Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SYRE

Spyre Therapeutics Inc

May 13 • 04:00PM ET

76.31

+1.27 1.69 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: LKFT ROIV APLS VERA KYMR

| Held by: IWM VTI XBI VXF IBB IWO SCHA VTWO IWN VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.36	Insider Own	13.26%	Shs Outstand	78.84M	Perf Week	4.53%
Market Cap	6.63B	Forward P/E	-	EPS next Y	-3.13	Insider Trans	-2.36%	Shs Float	75.33M	Perf Month	19.22%
Enterprise Value	6.04B	PEG	-	EPS next Q	-0.73	Inst Own	84.78%	Short Float	16.22%	Perf Quarter	124.97%
Income	-168.74M	P/S	-	EPS this Y	-46.88%	Inst Trans	23.44%	Short Ratio	11.05	Perf Half Y	244.05%
Sales	0.00M	P/B	11.68	EPS next Y	-7.68%	ROA	-25.30%	Short Interest	12.22M	Perf YTD	132.94%
Book/sh	6.53	P/C	8.94	EPS next 5Y	-22.06%	ROE	-29.26%	52W High	78.80 -3.16%	Perf Year	417.36%
Cash/sh	8.54	P/FCF	-	EPS past 3/5Y	57.01% 44.61%	ROIC	-25.15%	52W Low	13.93 447.81%	Perf 3Y	1893.73%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.42% 5.94%	Perf 5Y	-58.41%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	22.31%	Oper. Margin	-	ATR (14)	4.27	Perf 10Y	-57.43%
Dividend Ex-Date	-	Quick Ratio	8.97	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	67.36	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	8.97	EPS Q/Q	-46.71%	SMA20	5.65%	Beta	3.11	Target Price	95.20
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	33.65%	Rel Volume	0.70	Prev Close	75.04
Employees	102	LT Debt/Eq	0.00	Earnings	May 05 BMO	SMA200	127.85%	Avg Volume	1.11M	Price	76.31
IPO	Apr 07, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-11.18% -	Trades		Volume	775,469	Change	1.69%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)